Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Blood

• Publication date

  2000-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V95.3.783.003K33_783_789PMID 10648386
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SPSS (Statistical Package for the Social Sciences)

  2002cited by this paper
• New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project.

  1998cited by this paper
• A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma.

  1997cited by this paper
• IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.

  1997cited by this paper
• A pilot study on the use of the proMACE‐cytaBOM regimen as a first‐line treatment of advanced follicular non‐Hodgkin's lymphoma

  1997cited by this paper
• Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting.

  1997cited by this paper
• IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

  1997cited by this paper
• A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.

  1997cited by this paper
• High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma.

  1997cited by this paper
• Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.

  1996cited by this paper
• Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low‐grade non‐Hodgkin's lymphoma

  1996cited by this paper
• High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission.

  1996cited by this paper
• Elevated serum levels of soluble ICAM-1 are elevated in non-Hodgkin´s lymphomas and correlate with tumor burden, disease activity and other diagnostic markers

  1996cited by this paper
• Elevated serum levels of soluble ICAM‐1 in non‐Hodgkin’s lymphomas correlate with tumour burden, disease activity and other prognostic markers

  1996cited by this paper
• Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma.

  1996cited by this paper
• Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.

  1994cited by this paper
• Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.

  1994cited by this paper
• Prognostic factors in follicular lymphomas.

  1993cited by this paper
• Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.

  1993cited by this paper
• Natural history of and therapy for the indolent non-Hodgkin's lymphomas.

  1993cited by this paper
• Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma.

  1993cited by this paper
• Identification of prognostic groups in follicular lymphoma. The Scotland and Newcastle Lymphoma Group Therapy Working Party.

  1993cited by this paper
• A predictive model for aggressive non-Hodgkin's lymphoma.

  1993cited by this paper
• Original article: The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma

  1991cited by this paper
• Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.

  1991cited by this paper
• Low-grade follicular lymphomas: analysis of prognosis in a series of 281 patients.

  1991cited by this paper
• Phase I study of the combination of monthly carboplatin and weekly cisplatin.

  1991cited by this paper
• Prognostic value of serum beta-2 microglobulin in low-grade lymphoma.

  1991cited by this paper
• The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma. The Scotland and Newcastle Lymphoma Group Therapy Working Party.

  1991cited by this paper
• Follicular lymphomas: assessment of prognostic factors in 127 patients followed for 10 years.

  1991cited by this paper
• The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma.

  1991cited by this paper
• Prognostic Value of Serum β-2 Microglobulin in Low-Grade Lymphoma

  1991cited by this paper
• Maintenance chlorambucil after CVP in the management of advanced stage, low‐grade histologic type non‐Hodgkin's lymphoma: A randomized prospective study with an assessment of prognostic factors

  1988cited by this paper
• The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.

  1988cited by this paper
• Hodgkin's disease prognosis: a directly predictive equation.

  1988cited by this paper
• Follicular lymphoma: prognostic factors for response and survival.

  1986cited by this paper
• The Low-Grade Non-Hodgkin's Lymphomas: Challenges and Opportunities

  1985cited by this paper
• Serum albumin in Hodgkin's disease

  1985cited by this paper
• Karnofsky memorial lecture. The low-grade non-Hodgkin's lymphomas: challenges and opportunities.

  1985cited by this paper
• The natural history of initially untreated low-grade non-Hodgkin's lymphomas.

  1984cited by this paper
• The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation.

  1981cited by this paper
• Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.

  1978cited by this paper
• Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

  1976cited by this paper
• SPSS: statistical package for the social sciences

  1975cited by this paper
• Multivariate analysis of prognostic factors in the non‐Hodgkin's malignant lymphomas

  1974cited by this paper
• Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone.

  1972cited by this paper
• Statistical Package for the Social Sciences

  1970cited by this paper

• Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2025

  2026cites this paper
• PET/CT-Based prognostic model enhances early survival prediction in angioimmunoblastic t-cell lymphoma

  2025cites this paper
• End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial

  2024cites this paper
• Primary colorectal follicular lymphoma in a Savannah cat

  2024cites this paper
• A study of criteria for grading follicular lymphoma using a cell type classifier from pathology images based on complementary-label learning.

  2024cites this paper
• Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice

  2024cites this paper
• External Validation of the FLIPI Risk Score Measured at Diagnosis and POD24 Among Individuals With Follicular Lymphoma at the Time of Subsequent Relapse.

  2023cites this paper
• R‐CHOP treatment for patients with advanced follicular lymphoma: Over 15‐year follow‐up of JCOG0203

  2023cites this paper
• Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma

  2022cites this paper
• Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China

  2022cites this paper
• Prognostic ability of five clinical risk scores in follicular lymphoma: A single‐center evaluation

  2021cites this paper
• Female patients with follicular lymphoma have a better prognosis if primary remission lasts over 24 months

  2021cites this paper
• Past, present and future of prognostic scores in follicular lymphoma.

  2021cites this paper
• Clinical features and outcomes of 1845 patients with follicular lymphoma: a real-world multicenter experience in China

  2021cites this paper
• Advances in Treatment of Follicular Lymphoma

  2020cites this paper
• Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma

  2019cites this paper
• Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial

  2019cites this paper
• DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma.

  2019cites this paper
• Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model.

  2019cites this paper
• BMI-1 and survivin expression with clinicopathological correlation and prognostic impact in B and T/NK- cell non-Hodgkin lymphoma

  2019cites this paper
• Kadar hemoglobin awal sebagai faktor prognostik penderita limfoma non-hodgkin (LNH) yang menjalani kemoterapi

  2018cites this paper
• Aspectos epidemiológicos, clínicos e anatomopatológicos do linfoma folicular em cães

  2018cites this paper
• The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database

  2018cites this paper
• Current prognostic and predictive factors in follicular lymphoma

  2018cites this paper
• A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.

  2018cites this paper
• Prognostic impact of trisomy 21 in follicular lymphoma

  2018cites this paper
• Role of activation-induced cytidine deaminase (AID) in follicular lymphoma biology

  2017cites this paper
• Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients

  2017cites this paper
• The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma

  2017cites this paper
• Identification of polymorphisms in cancer patients that differentially affect survival with age

  2017cites this paper
• 14 Stratification of Patients with Follicular Lymphoma

  2017cites this paper
• Short Title: Survival in Follicular Lymphoma

  2017cites this paper
• Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges

  2016cites this paper
• Gastrointestinal follicular lymphoma: using primary site as a predictor of survival

  2016cites this paper
• Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.

  2016cites this paper
• Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis.

  2016cites this paper
• Follicular Lymphoma: The Management of Elderly Patient

  2016cites this paper
• Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States

  2016cites this paper
• Aberrant differential expression of EZH1 and EZH2 in Polycomb repressive complex 2 among B- and T/NK-cell neoplasms.

  2016cites this paper
• Follicular lymphoma patients with a high FLIPI score and a high tumor burden: a risk stratification model.

  2015cites this paper
• Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy

  2015cites this paper
• Serbian lymphoma study group: demografic characteristics of 257 patients with follicular lymphoma.

  2015cites this paper
• Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma).

  2015cites this paper
• Correlation Matrix Analysis Identifies Gene Signatures of Immune Cell Subsets and Their Interactions in Follicular Lymphoma

  2015influential citation
• A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry

  2015cites this paper
• Radiotherapy as an effective treatment modality for follicular lymphoma: a single institution experience

  2015cites this paper
• Analysis of clinical characteristics and prognostic factors for angioimmunoblastic T-cell lymphoma

  2015cites this paper
• The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL).

  2014cites this paper
• High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era

  2014cites this paper
• Circulating angiogenesis factors in patients with non-Hodgkin's lymphoma.

  2014cites this paper
• Introducción de Cetuximab en el tratamiento del carcinoma escamoso de cabeza y cuello

  2014cites this paper
• Improvement in survival of diffuse large B-cell lymphoma in relation to age, gender, International Prognostic Index and extranodal presentation: a population based Swedish Lymphoma Registry study

  2014cites this paper
• Optimal management of colorectal liver metastases in older patients: a decision analysis.

  2014cites this paper
• A Case of Recurred Follicular Lymphoma in Sublingual Gland after Complete Remission

  2014cites this paper
• Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma

  2013cites this paper
• Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study

  2013cites this paper
• Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial.

  2013cites this paper
• Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience.

  2013cites this paper
• Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices.

  2013cites this paper
• aggressiveness and to guide the choice of treatment Gene expression profiling in follicular lymphoma to assess clinical

  2013cites this paper
• Regression of follicular lymphoma of the duodenum following eradication of H. pylori infection.

  2013cites this paper
• previously untreated patients with follicular lymphoma Monitoring of minimal residual disease after CHOP and rituximab in

  2013cites this paper
• Anthracycline-containing regimens for treatment of follicular lymphoma in adults.

  2013cites this paper
• PROGNOSTIC AND PREDICTIVE MARKERS IN HEMATOLOGIC NEOPLASMS

  2012cites this paper
• ‘Watch and Wait’ as Initial Management for Patients with Follicular Lymphomas

  2012cites this paper
• Follicular lymphoma - treatment and prognostic factors

  2012cites this paper
• Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.

  2012cites this paper
• The Number of Lymphoma-associated Macrophages in Tumor Tissue Is an Independent Prognostic Factor in Patients With Follicular Lymphoma

  2012cites this paper
• Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial

  2012cites this paper
• Guidelines on the investigation and management of follicular lymphoma

  2012cites this paper
• Prognostic Assessment in Patients with Indolent B-Cell Lymphomas

  2012cites this paper
• Overview of the Lymphoid Neoplasms

  2012cites this paper
• Therapy of newly diagnosed follicular lymphoma

  2012cites this paper
• Prognostic and predictive markers in hematologic neoplasms. A review.

  2012cites this paper
• Stratification of Patients with Follicular Lymphoma

  2012cites this paper
• Prognostic factors in follicular lymphoma in the rituximab era: how to identify a high-risk patient?

  2011cites this paper
• Prognostic significance of biochemical markers in African Burkitt’s lymphoma

  2011cites this paper
• Nodal follicular lymphoma without complete follicular dendritic cell networks is related to localized clinical stage

  2011cites this paper
• Validity assessment of the cutaneous T-cell lymphoma severity index to predict prognosis in advanced mycosis fungoides/Sézary syndrome.

  2011cites this paper
• Clinical Features of Gastrointestinal Follicular Lymphoma: Comparison with Nodal Follicular Lymphoma and Gastrointestinal MALT Lymphoma

  2011cites this paper
• PET imaging in a longitudinal non-Hodgkin's lymphoma study: association with tumor volume

  2011cites this paper
• Diagnosis and treatment of follicular lymphoma.

  2011cites this paper
• Estudi del fenomen de la transformació histològica en síndromes limfoproliferatives indolents

  2010cites this paper
• Prognostic factors in follicular lymphoma.

  2010influential citation
• A decade of progress in lymphoma: advances and continuing challenges.

  2010cites this paper
• Severe Pulmonary Toxicity Associated with Fludarabine and Possible Contribution of Rituximab

  2010cites this paper
• Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival--A study from the groupe d'etude des lymphomes de l'adulte.

  2010cites this paper
• Prognostic factors and risk adaptation

  2010cites this paper
• Gastrointestinal follicular lymphoma: review of the literature

  2010cites this paper
• Presenting features of lymphoid neoplasms

  2010cites this paper
• Host factors for risk and survival in lymphoma.

  2010cites this paper
• Prognostic tools in follicular lymphomas

  2009cites this paper
• Prognostic factors in low-grade non-Hodgkin lymphomas

  2009cites this paper
• Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting.

  2009cites this paper
• Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

  2009cites this paper
• Role of hematopoietic stem cell transplant in the management of follicular lymphoma.

  2009cites this paper
• Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in Assessing Prognosis and Predicting First-Line Treatment Efficacy in Follicular Lymphoma Patients

  2009cites this paper
• Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage.

  2008cites this paper
• Tumors of the Hemolymphatic System

  2008cites this paper
• Follicular lymphomas.

  2008cites this paper